Predictive value of MITF gene amplification in metastatic melanoma patients receiving recombined human endostatin and dacarbazine as first-line treatment

doi:10.3969/j.issn.1009-0460.2013.06.004

Home>Articles>Predictive value of MITF gene amplification in metastatic melanoma patients receiving recombined human endostatin and dacarbazine as first-line treatment

DOI: 10.3969/j.issn.1009-0460.2013.06.004

Predictive value of MITF gene amplification in metastatic melanoma patients receiving recombined human endostatin and dacarbazine as first-line treatment

Keywords：Malignant melanomaRecombined human endostatin/EndostarDacarbazineMITF gene amplification

Publication Date：2013-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 494-497 )

Chinese Clinical Oncology

PKUISTIC

ISSN：1009-0460

Year, Vol.(Issue)：2013,18(6)